CRBU · Caribou Biosciences, Inc.
$1.65
+0.03 (+1.85%)
At close · Jul 21
Market Cap
$164.14M
Shares
99.18M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Rachel Haurwitz | CEO | $1,840,965 |
| Sriram Ryali | CFO | $1,029,413 |
| Barbara McClung | Chief legal officer and corporate secretary | $919,574 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Rachel Haurwitz | CEO | $4,213,245 |
| Tim Kelly | CTO | $1,913,370 |
| Barbara McClung | Chief legal officer and corporate secretary | $1,612,819 |
| Steven Kanner | Chief scientific officer | $1,612,819 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Rachel Haurwitz | CEO | $3,116,547 |
| Syed Rizvi | Chief medical officer | $1,268,277 |
| Steven Kanner | Chief scientific officer | $1,217,807 |
| Barbara McClung | Chief legal officer and corporate secretary | $1,217,807 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Syed Rizvi | Chief medical officer | $2,388,492 |
| Ruhi Khan | Chief business officer | $1,038,077 |
| Rachel Haurwitz | CEO | $833,468 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Rachel Haurwitz | CEO | $6,249,919 |
| Jason O’Byrne | CFO | $3,449,030 |
| Barbara McClung | Chief legal officer and corporate secretary | $2,743,054 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Rachel Haurwitz | CEO | $663,900 |
| Barbara McClung | Chief legal officer and corporate secretary | $504,150 |
| Jason O’Byrne | CFO | — |
Key facts
CIK
1619856
CUSIP
142038108
13F (30d)
12 filings
10 filers
Visit website
Investor relations